why choose us

300×250 Ad Slot

Research Article: Effect of accelerated high-fluence riboflavin and rose bengal-mediated corneal cross-linking on resistance to enzymatic digestion

Date Published: 2024-01-24

Introduction:
Corneal cross-linking (CXL) is a therapy originally used to treat corneal ectasias like keratoconus, pellucid marginal degeneration, postoperative ectasia, and keratoglobus with a number of clinical protocols varying irradiation time and fluence levels [1,2,3,4,5,6,7]. Subsequently, CXL indications were extended to include the treatment of infectious keratitis (IK) [2, 8,9,10].

Read more

300×250 Ad Slot